WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
Live Chat Live Help Software for Website

Idenix Pharmaceuticals, Inc.- Strategy and SWOT Report

MarketLine, September 2011, Pages: 35

Idenix Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Features:

- Detailed information on Idenix Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Idenix Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Idenix Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Idenix Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Idenix Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Idenix Pharmaceuticals (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. The company mainly focuses on the development of drugs for the treatment of viral hepatitis and HIV/AIDS. Idenix is headquartered in Cambridge, Massachusetts and employed 109 people as of December 31, 2010. The company recorded revenues of $10.2 million during the financial year ended December 2010 (FY2010), a decrease of 19% compared with FY2009. The operating loss of the company was $67.7 million during FY2010, as compared to operating loss of $54.4 million in FY2009. The net loss was $61.6 million in FY2010, as compared to net loss of $53.2 million in FY2009.

Reasons to Purchase:

- Gain understanding of Idenix Pharmaceuticals, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Idenix Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Idenix Pharmaceuticals, Inc.’s business structure, strategy and prospects

Company Snapshot
Idenix Pharmaceuticals, Inc.: Company Overview
Idenix Pharmaceuticals, Inc.: Overview and Key Facts
Idenix Pharmaceuticals, Inc.: Overview
Idenix Pharmaceuticals, Inc.: Key Facts
Idenix Pharmaceuticals, Inc.: Key Employees
Idenix Pharmaceuticals, Inc.: Key Employee Biographies
Idenix Pharmaceuticals, Inc.: Major Products and Services
Idenix Pharmaceuticals, Inc.: Company History
Idenix Pharmaceuticals, Inc.: Locations and Subsidiaries
Idenix Pharmaceuticals, Inc.: Key Competitors Idenix Pharmaceuticals, Inc.: Company Analysis
Idenix Pharmaceuticals, Inc.: Business Description
Idenix Pharmaceuticals, Inc.: SWOT Analysis
Idenix Pharmaceuticals, Inc.: SWOT Overview
Idenix Pharmaceuticals, Inc.: Strengths
Idenix Pharmaceuticals, Inc.: Weaknesses
Idenix Pharmaceuticals, Inc.: Opportunities
Idenix Pharmaceuticals, Inc.: Threats
Idenix Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Idenix Pharmaceuticals, Inc.: Financial Deals Overview
Idenix Pharmaceuticals, Inc.: Targets and Partners
Idenix Pharmaceuticals, Inc.: Top Deals 2007 -YTD-2012
Idenix Pharmaceuticals, Inc.: Advisors
Idenix Pharmaceuticals, Inc.: Top Legal Advisors
Idenix Pharmaceuticals, Inc.: Top Financial Advisors
Idenix Pharmaceuticals, Inc.: Capital Raising
Idenix Pharmaceuticals, Inc.: Partnership Idenix Pharmaceuticals, Inc.: Recent Developments
Idenix Pharmaceuticals, Inc.: News and Events Summary
Idenix Pharmaceuticals, Inc.: Corporate Governance
Idenix Pharmaceuticals, Inc.: Financial Performance
Idenix Pharmaceuticals, Inc.: Research & Development Appendix
Contact Us
Methodology
Definitions
About Datamonitor List of Tables Table 1: Idenix Pharmaceuticals, Inc.: Key Facts Table 2: Idenix Pharmaceuticals, Inc.: Key Employees Table 4: Idenix Pharmaceuticals, Inc.: Key Competitors Table 5: Idenix Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Table 6: Idenix Pharmaceuticals, Inc.: Targets and Partners Table 7: Idenix Pharmaceuticals, Inc.: Top Deals 2007 -YTD-2012 Table 8: Idenix Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m) Table 9: Idenix Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m) Table 10: Idenix Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2008 - YTD-2012) Table 11: Idenix Pharmaceuticals, Inc.: Capital Raising by Deal Type (2008 - YTD-2012) Table 12: Idenix Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2008 - YTD-2012) Table 13: Idenix Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2008 - YTD-2012) Table 14: Idenix Pharmaceuticals, Inc.: News and Events Summary Table 15: Idenix Pharmaceuticals, Inc.: Corporate Governance Table 16: Idenix Pharmaceuticals, Inc.: Financial Performance Table 17: Idenix Pharmaceuticals, Inc.: Research & Development List of Figures Figure 1: Idenix Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Figure 2: Idenix Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2008 - YTD-2012) Figure 3: Idenix Pharmaceuticals, Inc.: Capital Raising by Deal Type (2008 - YTD-2012) Figure 4: Idenix Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2008 - YTD-2012) Figure 5: Idenix Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2008 - YTD-2012)

Customers who bought this item also bought